Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Food Funct ; 12(19): 9339-9346, 2021 Oct 04.
Artigo em Inglês | MEDLINE | ID: mdl-34606551

RESUMO

The present study investigated whether combined ingestion of green tea catechins (GTC) and monoglucosyl hesperidin (GHES) influences the pharmacokinetic parameters of polyphenols and serum triglycerides (TG). We conducted 2 randomized, controlled trials. Study 1: 8 healthy male subjects participated in a crossover study in which they ingested a test beverage containing GHES (0, 84, 168, or 336 mg GHES) with GTC, or 336 mg GHES without GTC. After ingestion, the pharmacokinetic changes in plasma hesperetin (HEP) and catechins were measured. Study 2: 36 healthy male and female subjects (mean age, 53 ± 2 years; mean BMI, 25.2 ± 0.5 kg m-2) were recruited for a double-blind, placebo-controlled study in which they ingested a test beverage containing 165 mg GHES with 387 mg GTC or a placebo beverage daily for 4 weeks. Fasting serum TG and other lipids and glucose metabolites were analyzed. Study 1 showed that the pharmacokinetics of HEP did not differ significantly between the 336 mg GHES without GTC treatment and the 168 mg GHES with GTC treatment. Study 2 showed that continuous ingestion of 165 mg GHES and 387 mg GTC for 4 weeks significantly decreased fasting serum TG levels compared with baseline values (change in TG, -30 ± 13 mg dl-1, P = 0.040) in the intention-to-treat analysis. In conclusion, our findings suggest that GTC affects the oral bioavailability of GHES, and combined ingestion of low doses of GHES with GTC effectively improves fasting TG levels.


Assuntos
Bebidas , Catequina/administração & dosagem , Glucosídeos/administração & dosagem , Glucosídeos/farmacocinética , Hesperidina/análogos & derivados , Chá , Triglicerídeos/sangue , Adulto , Estudos Cross-Over , Método Duplo-Cego , Feminino , Hesperidina/administração & dosagem , Hesperidina/sangue , Hesperidina/farmacocinética , Humanos , Masculino , Pessoa de Meia-Idade , Método Simples-Cego
2.
J Appl Physiol (1985) ; 117(11): 1337-48, 2014 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-25257874

RESUMO

Obesity is now a worldwide health problem. Glucose-dependent insulinotropic polypeptide (GIP) is a gut hormone that is secreted following the ingestion of food and modulates energy metabolism. Previous studies reported that lowering diet-induced GIP secretion improved energy homeostasis in animals and humans, and attenuated diet-induced obesity in mice. Therefore, food-derived GIP regulators may be used in the development of foods that prevent obesity. Rice bran oil and its components are known to have beneficial effects on health. Therefore, the aim of the present study was to clarify the effects of the oil-soluble components of rice bran on postprandial GIP secretion and obesity in mice. Triterpene alcohols [cycloartenol (CA) and 24-methylene cycloartanol (24Me)], ß-sitosterol, and campesterol decreased the diet-induced secretion of GIP in C57BL/6J mice. Mice fed a high-fat diet supplemented with a triterpene alcohol and sterol preparation (TASP) from rice bran for 23 wk gained less weight than control mice. Indirect calorimetry revealed that fat utilization was higher in TASP-fed mice than in control mice. Fatty acid oxidation-related gene expression in the muscles of mice fed a TASP-supplemented diet was enhanced, whereas fatty acid synthesis-related gene expression in the liver was suppressed. The treatment of HepG2 cells with CA and 24Me decreased the gene expression of sterol regulatory element-binding protein (SREBP)-1c. In conclusion, we clarified for the first time that triterpene alcohols and sterols from rice bran prevented diet-induced obesity by increasing fatty acid oxidation in muscles and decreasing fatty acid synthesis in the liver through GIP-dependent and GIP-independent mechanisms.


Assuntos
Álcoois/uso terapêutico , Metabolismo Energético/efeitos dos fármacos , Polipeptídeo Inibidor Gástrico/metabolismo , Obesidade/prevenção & controle , Fitosteróis/uso terapêutico , Período Pós-Prandial/efeitos dos fármacos , Triterpenos/uso terapêutico , Álcoois/farmacologia , Animais , Dieta Hiperlipídica , Ácidos Graxos/metabolismo , Células Hep G2 , Humanos , Gordura Intra-Abdominal/metabolismo , Fígado/metabolismo , Masculino , Camundongos Endogâmicos C57BL , Oryza , Fitosteróis/sangue , Fitosteróis/farmacologia , Fitoterapia , Triterpenos/sangue , Triterpenos/farmacologia , Aumento de Peso
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA